" class="no-js "lang="en-US"> Hyperfine Announces Plans for Global Expansion Starting with Launches in the United Kingdom and Pakistan - Medtech Alert
Thursday, June 20, 2024

Hyperfine Announces Plans for Global Expansion Starting with Launches in the United Kingdom and Pakistan

Hyperfine, Inc., creator of the first FDA-cleared portable magnetic resonance imaging (MRI) device, Swoop™, today announced plans for expansion in the United Kingdom (U.K.) and Pakistan, along with the hires of Yossi Cohen, M.D. as its U.K. senior medical director and Omer Manya as its business development partnership manager for Pakistan.

Hyperfine’s U.K. expansion will be spearheaded by Yossi Cohen, M.D., who joins the company as U.K. senior medical director. He will be responsible for overseeing the U.K. office, including clinical operations, commercial operations, and regulatory activities to help Hyperfine achieve its goal of helping healthcare providers reduce barriers to life-saving treatment.

Dr. Cohen brings over 20 years of multidisciplinary experience in medicine and research, engineering, and software development. Most recently, Dr. Cohen served as physician executive for InterSystems U.K., leading implementations of longitudinal care records and electronic health records across the National Health Service (NHS).

Omer Manya will lead Hyperfine’s Pakistan expansion and be responsible for growing the adoption of the Swoop system. He brings decades of strategic technology experience in research and development in healthcare and other sectors. He most recently served as IT director of infrastructure and operations at Aga Khan University in Karachi.

Medequips, a Pakistan-based company specializing in providing innovative diagnostic imaging equipment for hospitals and clinics, will execute marketing, distribution, and sales of the Swoop system in the country.

“The promise of Hyperfine is to dramatically increase the presence of MRI in clinical environments around the world. Expansion to the U.K. and Pakistan is a milestone moment and tremendous opportunity as we step forward to meet the global demand for better imaging access and ultimately drive a more comprehensive and efficient care continuum,” said Dave Scott, Hyperfine president and chief executive officer.  “We are fortunate to have Yossi and Omer join the Hyperfine team, as their extensive experience and passion for technological innovation will be instrumental at this important stage of Hyperfine’s global growth.”

Hyperfine’s Swoop system is designed to allow physicians to rapidly diagnose brain and head injuries and make life-saving decisions. Within minutes, the technology can acquire critical images via a wireless tablet, powered by a standard wall outlet at the patient’s bedside, whether in the ICU, ER, or other care setting.

Hyperfine will attend several upcoming conferences in the U.K. and Pakistan. The company recently exhibited at the Defense Security Equipment International ConferenceSeptember 14-17, 2021, where it showcased the Swoop system with live product demos.

Hyperfine’s U.K. and Pakistan expansion is the beginning of the company’s plans for accelerated commercial expansion to four additional countries within the next six months.

People In This Post

Companies In This Post

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more